Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
01 3AMMONIUM LACTATE
02 1CAPITAL AND CODEINE
03 8CLOBAZAM
04 1E.E.S.
05 1E.E.S. 400
06 2EMFLAZA
07 1ERYPED
08 2EURAX
09 1FLOLIPID
10 1FURADANTIN
11 2GRISEOFULVIN
12 1KIONEX
13 2LAC-HYDRIN
14 1LIKMEZ
15 1NAPROSYN
16 1NAPROXEN
17 1NITROFURANTOIN
18 3NYSTATIN
19 3PHENYTOIN
20 1PRAVASTATIN SODIUM
21 1SELSUN
22 2SODIUM POLYSTYRENE SULFONATE
23 1TIOCONAZOLE
24 1TRI-LUMA
01 16927
02 17936
03 19112
04 19175
05 118965
06 119155
07 120508
08 121112
09 140028
10 140342
11 140521
12 250207
13 161905
14 162512
15 162876
16 165200
17 165438
18 174190
19 175570
20 175774
21 175915
22 176216
23 176939
24 186024
25 189049
26 189892
27 190590
28 1201355
29 1203621
30 1206679
31 1208684
32 1208685
33 1208819
34 1209715
35 1210039
36 1210546
37 1210569
38 1210746
39 1211259
40 1213110
41 1216755
01 40No
02 2Yes
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Drug : NITROFURANTOIN
Dosage Form : SUSPENSION; ORAL
Application Number : 201355
Country : US
Patented : No
Drug : NAPROSYN
Dosage Form : SUSPENSION; ORAL
Application Number : 18965
Country : US
Patented : No
Drug : CLOBAZAM
Dosage Form : SUSPENSION; ORAL
Application Number : 208819
Country : US
Patented : No
Drug : CLOBAZAM
Dosage Form : SUSPENSION; ORAL
Application Number : 211259
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Drug : NYSTATIN
Dosage Form : SUSPENSION; ORAL
Application Number : 62512
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Drug : AMMONIUM LACTATE
Dosage Form : LOTION; TOPICAL
Application Number : 76216
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
